Position in LGND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$33,387,267
-$3,179,245 QoQ
Shares Held
167,229
-13.5% QoQ
Ownership
0.834%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 80.34671019978592.ToString("F0")%
Shared 0.ToString("F0")%
None 19.653289800214075.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. LGND ranks #68 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in LGND
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,387,267 | 167,229 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $36,566,512 | 193,402 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $33,426,493 | 188,701 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $23,009,853 | 202,409 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $25,138,129 | 239,092 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $22,272,411 | 207,862 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $23,722,629 | 237,013 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $16,374,916 | 194,338 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $18,413,668 | 251,897 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $14,226,431 | 199,194 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $11,684,815 | 195,007 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $12,131,975 | 168,266 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $11,407,608 | 155,079 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $12,329,271 | 184,570 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,471,080 | 120,464 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,249,138 | 148,211 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $10,004,663 | 142,568 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $7,509,370 | 77,933 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,305,481 | 95,562 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,305,143 | 89,261 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $6,199,470 | 65,187 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,883,239 | 46,474 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $6,024,661 | 101,317 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,687,698 | 52,851 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $854,854 | 18,844 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||